ARTICLES

Synthesis and Bioactivity Study of Benzimidazole Derivatives with Fluorescent Self-Labeling and Tubulin Polymerization Inhibition

  • Haiyang Dong ,
  • Jiaxin Pu ,
  • Keke Li ,
  • Haowen Zhang ,
  • Xiaoqing Geng ,
  • Tingting Liang ,
  • Jianhong Wang
Expand
  • Henan Key Laboratory of Natural Medicine Innovation and Transformation, Henan University, Kaifeng, Henan 475004

Received date: 2024-07-29

  Revised date: 2024-09-14

  Online published: 2024-10-29

Supported by

Key Scientific Research Program of the Higher Education Institutions of Henan Province(24A350001); Key Scientific and Technological Projects of Henan Province(242102310439)

Abstract

A series of novel Combretastatin A-4-based benzimidazole derivatives were designed and synthesized according to rational drug design strategies. The antiproliferation activities were preliminarily evaluated against cancer cell line HT-29, and compound IV-02 stood out from the target compounds and exhibited significant antiproliferation potency. Further evaluation on multiple cancer cell lines such as HT-1080, HepG2, A549 and A549/Taxol cells, demonstrated that compound IV-02 showed significant cell growth inhibition on A549 cells with IC50 of 0.18 µmol/L, which was comparable to that of positive control colchicine (IC50=0.15 µmol/L). Further mechanistic studies demonstrated that IV-02 could inhibit tubulin polymerization in a concentration-dependent manner, cause cell cycle arrest in G2/M phase and induce the cell apoptosis. In addition, IV-02 exhibited fluorescence emission effect, which would be beneficial to label the intracellular dynamic changes of IV-02 in real time. The results indicated that compound IV-02 could serve as an anticancer compound with fluorescent self-labeling properties.

Cite this article

Haiyang Dong , Jiaxin Pu , Keke Li , Haowen Zhang , Xiaoqing Geng , Tingting Liang , Jianhong Wang . Synthesis and Bioactivity Study of Benzimidazole Derivatives with Fluorescent Self-Labeling and Tubulin Polymerization Inhibition[J]. Chinese Journal of Organic Chemistry, 2025 , 45(4) : 1315 -1324 . DOI: 10.6023/cjoc202407044

References

[1]
Hamel, E.; Lin, C. M. Biochem. Pharmacol. 1983, 32, 3864.
[2]
Tron, G. C.; Pirali, T.; Sorba, G.; Pagliai, F.; Busacca, S.; Genazzani, A. A. J. Med. Chem. 2006, 49, 3033.
[3]
Cui, Y. J.; Liu, C.; Ma, C. C.; Ji, Y. T.; Yao, Y. L.; Tang, L. Q.; Zhang, C. M.; Wu, J. D.; Liu, Z. P. J. Med. Chem. 2020, 63, 14840.
[4]
Seddigi, Z. S.; Malik, M. S.; Saraswati, A. P.; Ahmed, S. A.; Babalghith, A. O.; Lamfon, H. A.; Kamal, A. MedChemComm 2017, 8, 1592.
[5]
Gaspari, R.; Prota, A. E.; Bargsten, K.; Cavalli, A.; Steinmetz, M. O. Chem 2017, 2, 102.
[6]
Pecnard, S.; Hamze, A.; Bignon, J.; Prost, B.; Deroussent, A.; Gallego-Yerga, L.; Peláez, R.; Paik, J. Y.; Diederich, M.; Alami, M.; Provot, O. Eur. J. Med. Chem. 2021, 223, 113656.
[7]
Bukhari, S. N. A.; Kumar, G. B.; Revankar, H. M.; Qin, H. L. Bioorg. Chem. 2017, 72, 130.
[8]
Shan, Y.; Zhang, J.; Liu, Z.; Wang, M.; Dong, Y. Curr. Med. Chem. 2011, 18, 523.
[9]
Gu, Y. F.; Wu, C. J.; Wang, S. Q.; Zhang, S. L.; Lu, Y.; Si, X. X.; Jiang, B. L. Chin. J. Org. Chem. 2024, 44, 3497. (in Chinese)
[9]
(顾一飞, 吴彩菊, 王思琪, 张世琳, 陆远, 司鑫鑫, 蒋佰玲, 有机化学, 2024, 44, 3497.)
[10]
Kremmidiotis, G.; Leske, A. F.; Lavranos, T. C.; Beaumont, D. Mol. Cancer Ther. 2010, 9, 1562.
[11]
Flynn, B. L.; Gill, G. S.; Grobelny, D. W.; Chaplin, J. H.; Paul, D.; Leske, A. F.; Lavranos, T. C.; Chalmers, D. K.; Charman, S. A.; Kostewicz, E. J. Med. Chem. 2011, 54, 6014.
[12]
Wang, Q. H.; Arnst, K. E.; Wang, Y. X.; Kumar, G.; Ma, D. J.; White, S. W.; Miller, D. D.; Li, W. M.; Li, W. J. Med. Chem. 2019, 62, 6734.
[13]
Kashyap, V. K.; Wang, Q. H.; Setua, S.; Nagesh, P. K. B.; Chauhan, N.; Kumari, S.; Chowdhury, P.; Miller, D. D.; Yallapu, M. M.; Li, W.; Jaggi, M.; Hafeez, B. B.; Chauhan, S. C. J. Exp. Clin. Cancer Res. 2019, 38, 29.
[14]
Lai, Q. H.; Wang, Y. X.; Wang, R. X.; Lai, W. R.; Tang, L. Z.; Tao, Y. R.; Liu, Y.; Zhang, R. R.; Huang, L. Y.; Xiang, H. T.; Zeng, S. X.; Gou, L. T.; Chen, H.; Yao, Y. Q.; Yang, J. L. Eur. J. Med. Chem. 2018, 156, 162.
[15]
Huo, Z.; Liu, K.; Zhang, X.; Liang, Y.; Sun, X. Eur. J. Med. Chem. 2022, 235, 114271.
[16]
Li, G.; Wu, J. Q.; Cai, X. J.; Guan, W.; Zeng, Z. J.; Ou, Y. H.; Wu, X. Y.; Li, J. Y.; Fang, X. X.; Liu, J. L.; Zhang, Y. L.; Wang, H. M.; Yin, C. Q.; Yao, H. L. Eur. J. Med. Chem. 2023, 252, 115284.
[17]
Karetnikov, G. L.; Vasilyeva, L. A.; Babayeva, G.; Pokrovsky, V. S.; Skvortsov, D. A.; Bondarenko, O. B. ACS Pharmacol. Transl. Sci. 2024, 7, 384.
[18]
Tan, Y. C.; Hu, H.; Zhu, W. J.; Wang, T.; Gao, T.; Wang, H. Q.; Chen, J.; Xu, J. Y.; Xu, S. T.; Zhu, H. J. Eur. J. Med. Chem. 2023, 262, 115881.
[19]
Li, Y.; Ma, H. Q.; Wang, Y. L. Chin. J. Org. Chem. 2008, 28, 210. (in Chinese)
[19]
(李焱, 马会强, 王玉炉, 有机化学, 2008, 28, 210.)
[20]
Santosh, P. C.; Pandeya, S. N.; Pathak, A. K. Int. J. Res. Ayurveda Pharm. 2001, 2, 1726.
[21]
Dong, H. Y. Ph.D. Dissertation, Henan University, Kaifeng, 2024. (in Chinese)
[21]
(冬海洋. 博士论文, 河南大学, 开封, 2024).
Outlines

/